Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

NCT06932861 is registered in ClinicalTrials.gov with Xinxin Zhang as lead sponsor.

NCT NCT06932861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06932861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Lead sponsor
Xinxin Zhang
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
May 1, 2028
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rhabdomyosarcoma